Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP11B2 | P19099 | 4/20 | 0.46 |
| ▸ | CYP11B1 | P15538 | 3/20 | 0.46 |
| ▸ | KCNA5 | P22460 | 6/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.42 |
| ▸ | TDO2 | P48775 | 1/20 | 0.37 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.37 |
| ▸ | FFAR4 | Q5NUL3 | 2/20 | 0.37 |
| ▸ | RPS6KA3 | P51812 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.36 |
| ▸ | ELOVL1 | Q9BW60 | 1/20 | 0.36 |
| ▸ | PDE5A | O76074 | 1/20 | 0.35 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4975773 | 0.85 | KCNA5 (0.39) | CYP11B2CYP11B1KCNA5KCNH2PDE5A | |
| SCHEMBL4980305 | 0.85 | KCNA5 (0.39) | CYP11B2CYP11B1KCNA5KCNH2FFAR1 | |
| SCHEMBL4977530 | 0.84 | CYP11B1 (0.48) | CYP11B2CYP11B1KCNA5KCNH2 | |
| SCHEMBL4979558 | 0.82 | CYP11B2 (0.48) | CYP11B2CYP11B1KCNA5KCNH2 | |
| SCHEMBL4982009 | 0.80 | MKNK1 (0.47) | CYP11B2CYP11B1KCNA5KCNH2 | |
| SCHEMBL4974371 | 0.79 | KCNA5 (0.50) | CYP11B2CYP11B1KCNA5KCNH2 | |
| SCHEMBL4977077 | 0.78 | CYP11B1 (0.53) | CYP11B2CYP11B1 | |
| SCHEMBL4977669 | 0.78 | CYP11B1 (0.54) | CYP11B2CYP11B1KCNA5KCNH2 | |
| SCHEMBL4975675 | 0.78 | MKNK1 (0.47) | CYP11B2CYP11B1KCNA5RPS6KA3 | |
| SCHEMBL4975470 | 0.78 | KCNA5 (0.51) | CYP11B2CYP11B1KCNA5KCNH2RPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1993551-A2 | POTASSIUM CHANNEL INHIBITORS | Merck & Co., Inc. (US) | 2008-11-26 | — | — | EP | claimed |
| WO-2007089735-A2 | POTASSIUM CHANNEL INHIBITORS | MERCK & CO., INC. (US) | 2007-08-09 | — | — | WO | claimed |